Boston Scientific Advances 'Pilot-and-First' Initiatives to Support Hainan Free Trade Port Development

Boao, HainanApril 13, 2021 /PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) once again showcased its portfolio of star products at the “Never-Ending” International Innovative Drugs and Medical Devices Exhibition in the Boao Lecheng International Medical Tourism Pilot Zone, highlighting its cutting-edge solutions in the field of minimally invasive interventional procedures. At the concurrently held Boao Lecheng 2020 Annual Summary Conference on International Innovative Drugs and Medical Devices, Boston Scientific and its flagship product, the Rezūm Water Vapor Thermal Therapy System, were respectively awarded the “Best Partner Award” and the “Best Star Product Award for International Innovative Drugs and Medical Devices” by the Administration Bureau of the Boao Lecheng International Medical Tourism Pilot Zone, in recognition of their innovative explorations under the “Pilot and First-Use” policy and their outstanding therapeutic performance.

Boston Scientific Makes Another Appearance at the “Never-Ending” International Innovative Drugs and Medical Devices Exhibition

Boston Scientific Wins “Best Partner Award” and “Best Star Product Award for International Innovative Drugs and Medical Devices”

“The first year of the 14th Five-Year Plan, winning these two honors in China’s only ‘Medical Special Zone’ is a tremendous encouragement to Boston Scientific’s continuous integration into the local healthcare ecosystem and its commitment to benefiting Chinese patients and healthcare providers,” said Ms. Zhang Jun, President of Greater China at Boston Scientific. “From exploring innovation to leading innovation, over the three years since the establishment of the Hainan Free Trade Port, the Lecheng Pilot Zone has gradually developed a unique ‘Lecheng Model’ and accumulated valuable experience, becoming a strategic hub for advancing the construction of the Hainan Free Trade Port and comprehensively deepening reform and opening-up. Boston Scientific is committed to partnering with the Lecheng Pilot Zone to continue exploring ‘pilot initiatives,’ introducing advanced international products, and supporting the zone’s reform and innovation through concrete actions, thereby propelling the development of the Hainan Free Trade Port toward new milestones.”

Highlight Products Debut; Pilot Initiatives Advance Steadily

As a “veteran” of the medical device exhibition, Boston Scientific is participating for the second time with a completely upgraded booth. Featuring a dual-ring design that symbolizes the “dual circulation” strategy, the booth will comprehensively showcase 63 flagship products from multiple perspectives. Leveraging the momentum of the “pilot trial” policies, Boston Scientific aims to connect with international markets and facilitate the global circulation through deepened localization efforts.

Boston Scientific’s Double-Ring Booth Highlighting the “Dual Circulation” Concept

The exhibited products span multiple critical and chronic disease management areas, including cardiovascular and cerebrovascular diseases, atrial fibrillation and stroke prevention, interventional therapy for liver cancer, digestive endoscopic interventional therapy, and urological and women’s health. Notably, the *Rezūm Thermal Therapy Ablation System, which won the “Best Star Product Award for International Innovative Drugs and Medical Devices,” is the world’s first water vapor thermal therapy ablation system for treating benign prostatic hyperplasia (BPH). It offers advantages such as short procedure time, rapid recovery, and high safety, making it suitable for widespread adoption as a day-case surgery in primary care hospitals.

Last December, the internationally leading Rezūm water vapor thermal therapy ablation system was launched in Boao Lecheng, where the first domestic case of prostatic water vapor thermal therapy ablation surgery was successfully performed. This also marked Boston Scientific’s first “pilot trial” procedure in the Lecheng Pilot Zone. To date, nearly 30 procedures have been completed using the Rezūm system. The outstanding performance of the Rezūm “pilot trial” will further accelerate its entry into the Chinese market, thereby benefiting a broad population of patients with benign prostatic hyperplasia (BPH) at an earlier stage and contributing to the realization of the “Healthy China” goal of “joint construction, shared benefits, and universal health.”

Innovative Exploration Never Ends; Open Cooperation Composes a New Chapter

As a long-term partner of the Boao Lecheng International Medical Tourism Pilot Zone and the medical device company with the largest number of products in the second batch of real-world data pilot programs, Boston Scientific currently has three products selected for real-world data studies. These include the Rezūm Water Vapor Thermal Therapy System, the world’s first single-use duodenoscope, EXALT Model D, and the SpaceOAR Hydrogel System, which is used to reduce common side effects of radiation therapy for prostate cancer. This enables Chinese patients to access the latest international medical services without leaving the country.

Commenting on Boston Scientific’s receipt of the “Best Partner Award” in the Boao Lecheng Pilot Zone, Gu Gang, Director of the Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration, stated: “The Lecheng Pilot Zone enjoys policy advantages such as ‘three synchronizations’ and the ‘pilot implementation of real-world data applications in clinical practice.’ However, translating these policy benefits into tangible outcomes depends on collaborative innovation with globally leading medical technology companies like Boston Scientific. This partnership is essential to establishing Lecheng as a gateway for innovative pharmaceuticals and medical devices to enter the Chinese market, thereby delivering accessible health benefits to patients in China.”

Always operating as an “insider” to deeply cultivate the local Chinese market, Boston Scientific adheres to its mission and vision of “effectively bridging international innovative medical technologies with domestic health needs.” The company has continuously strengthened its collaboration with the Boao Lecheng Pilot Zone, taking concrete actions to support high-level opening-up in China’s medical device sector. On January 21, 2020, Boston Scientific signed a strategic cooperation agreement with the Administration Bureau of the Boao Lecheng International Medical Tourism Pilot Zone, becoming the first medical device enterprise partner of the Pilot Zone in the field of real-world data (RWD) research. This partnership aims to assist the Pilot Zone in establishing a pilot platform for real-world data on medical devices and jointly promote the globalization of China’s medical device industry.

*This product is not yet available in mainland China

About Boston Scientific

Boston Scientific Corporation is committed to innovating for life. We are dedicated to developing innovative medical solutions that improve the lives of patients worldwide. For more than 40 years, Boston Scientific has been a leader in the global medical technology industry, offering a broad portfolio of high-performance medical solutions to meet the urgent therapeutic needs of a wide patient population and reduce healthcare costs. For more information, please visit the company’s website:www.bostonscientific.cn

About Boston Scientific Greater China

Boston Scientific established its China headquarters in Shanghai in 1997 and currently maintains branch offices in Beijing, Shanghai, Guangzhou, Chengdu, Hong Kong, and Taiwan. The company’s core business areas encompass interventional cardiology, structural heart disease, cardiac rhythm management and electrophysiology, endoscopic interventions, peripheral and neurovascular interventions, urology and pelvic health, and respiratory products. Upholding its tradition as an innovation leader, Boston Scientific is committed to becoming a respected medical technology company that is responsive to the needs of patients and healthcare providers, driven by innovative vitality, through the provision of high-quality medical products and services for prevention, diagnosis, and treatment. For more detailed information, please visit the company website:www.bostonscientific.cn